SZSE: 000661 - Changchun High-Tech Industries (Group) Inc.

Yield per half year: -38.25%
Dividend yield: +0.72%
Sector: Healthcare

Changchun High-Tech Industries (Group) Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
14.59 69.4 -78.98% 42.65 -65.79%
P/S 4.53 6.51 -30.38%
P/BV 2.95 3.96 -25.43%
P/FCF 0 0 0%
Ev/Ebitda 11.05 11.85 -6.74%
Ev/S 4.12 5.98 -30.97%
Ev/FCF 0 0 0%
E/P 0.0691 0.0396 74.52%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
36.92 16.34 125.94% 42.3 -12.72%
ROE 19.79 11.95 65.67%
ROA 11.44 5.4 111.79%
ROIC 0 0 0%
ROS 31.05 16.23 91.28%
ROCE 0 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.274 14.63 -98.13% 0.2767 -0.9911%
Nеt Debt/Ebitda 0 0 0%
Debt/Ratio 0 0 0%
Debt/Equity 0 0 0%
Debt/Net Income 0.3549 3.6 -90.14%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
1.8/10
0.72 1.83 -60.72% 0.3009 +139.28%
Number of years of dividend growth 1 1.44 -30.43%
DSI 1 0.9113 9.73%
Average dividend growth 12.92 10.4 24.26%
Average percentage for 5 years 0.3009 1.14 -73.65%
Average percentage for payments 198.97 44.8 344.12%
Difference from average difference in sector -1.11

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
9/10
97.54 61.43 58.78%
Growth impulse Ebitda in 5 years 192.83 158.62 21.57%
Growth impulse Net Income in 5 years 155.35 66.93 132.11%
Growth impulse FCF in 5 years 175.91 248.41 -29.19%
Growth impulse EPS in 5 years 107.55 73.29 46.75%
IP Score
7.32/10

Similar companies

Aier Eye Hospital Group Co., Ltd.

Imeik Technology Development Co.,Ltd.

Hangzhou Tigermed Consulting Co., Ltd

Chongqing Zhifei Biological Products Co

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription